These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Yao Y, Hu Z, Ye J, Hu C, Song Q, Da X, Yu Y, Li H, Xu C, Chen Q, Wang QK. J Am Heart Assoc; 2017 Jun 25; 6(6):. PubMed ID: 28649088 [Abstract] [Full Text] [Related]
7. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model. Jang HS, Nam HY, Kim JM, Hahm DH, Nam SH, Kim KL, Joo JR, Suh W, Park JS, Kim DK, Gwon HC. Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):881-8. PubMed ID: 19496118 [Abstract] [Full Text] [Related]
8. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells. Lee KP, Sudjarwo GW, Jung SH, Lee D, Lee DY, Lee GB, Baek S, Kim DY, Lee HM, Kim B, Kwon SC, Won KJ. Atherosclerosis; 2015 Jun 15; 240(2):367-73. PubMed ID: 25875388 [Abstract] [Full Text] [Related]
9. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate. Song SH, Kim K, Jo EK, Kim YW, Kwon JS, Bae SS, Sung JH, Park SG, Kim JT, Suh W. Arterioscler Thromb Vasc Biol; 2016 Sep 15; 36(9):1928-36. PubMed ID: 27470512 [Abstract] [Full Text] [Related]
12. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury. Jaschke B, Milz S, Vogeser M, Michaelis C, Vorpahl M, Schömig A, Kastrati A, Wessely R. FASEB J; 2004 Aug 15; 18(11):1285-7. PubMed ID: 15180955 [Abstract] [Full Text] [Related]
13. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan. Segev A, Nili N, Osherov AB, Qiang B, Wong AJ, Pillarisetti S, Strauss BH. EuroIntervention; 2010 May 15; 6(1):134-40. PubMed ID: 20542809 [Abstract] [Full Text] [Related]
14. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Curcio A, Torella D, Indolfi C. Circ J; 2011 May 15; 75(6):1287-96. PubMed ID: 21532177 [Abstract] [Full Text] [Related]
17. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury. Yan G, Wang Q, Hu S, Wang D, Qiao Y, Ma G, Tang C, Gu Y. Int J Mol Med; 2015 Oct 15; 36(4):1001-11. PubMed ID: 26311435 [Abstract] [Full Text] [Related]
19. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Duran-Prado M, Morell M, Delgado-Maroto V, Castaño JP, Aneiros-Fernandez J, de Lecea L, Culler MD, Hernandez-Cortes P, O'Valle F, Delgado M. Circ Res; 2013 May 24; 112(11):1444-55. PubMed ID: 23595952 [Abstract] [Full Text] [Related]
20. Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells. Hwang JS, Ham SA, Yoo T, Lee WJ, Paek KS, Lee CH, Seo HG. Mol Pharmacol; 2016 Nov 24; 90(5):522-529. PubMed ID: 27573670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]